The groundbreaking therapy of tirzepatide peptide represents a exciting breakthrough in the handling of the condition. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to enhanced glucose regulation and potential reduction in weight